The risk of adverse events varies among asthma biologics, according to FDA data

(MedPage Today) – Chicago – The risk of adverse events varied across biologics used by asthma patients, an analysis of data submitted to the US Food and Drug Administration’s Adverse Event Reporting System (FAERS) showed. In comparing the relative number of reports from 2004 to 2024…